 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/10 mg comp.x 28 | $50.444,32 | (20/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $25.222,16 |
|
|
|
|
| 160/12.5/5 mg comp.x 28 | $50.928,86 | (20/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $25.464,43 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $50.928,86 | (20/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $25.464,43 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $50.928,86 | (20/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $25.464,43 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $53.860,12 | (20/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.930,06 |
|
|
|
|
| |
